Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Mutant endoglycoceramidases with enhanced synthetic activity

Mutant endoglycoceramidases with enhanced synthetic activity

US Patent 9068208 · Granted Jun 30, 2015

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ulinastatin polypeptides2023
Compositions and methods for neuraminidase detection and quantification2023
Amylase inhibitor compounds, methods of their use and compositions thereof2023
Method of treating fibroblast growth factor 21 (FGF-21) deficiency2020
Mammalian glucosidase inhibitors, methods for their use and pharmaceutical compo2020
Glycolipids as treatment for disease2020
Mutant endoglycoceramidases with enhanced synthetic activity2019
Mutant endoglycoceramidases with enhanced synthetic activity2019
Mutant endoglycoceramidases with enhanced synthetic activity2019
Mutant endoglycoceramidases with enhanced synthetic activity2019
Hydrolysis resistant sialic acid derivatives and methods for their use2018
3′ equatorial-fluorine-substituted neuraminidase inhibitor compounds, compositio2018